Aspire Biopharma Holdings, Inc.
ASBP
$1.06
-$0.14-11.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.48M | -20.54M | -18.90M | -17.02M | -1.31M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 8.02M | 2.02M | -- | -- | -- |
| Total Other Non-Cash Items | 11.00M | 14.10M | 15.70M | 14.52M | -- |
| Change in Net Operating Assets | 533.40K | 897.00K | 299.30K | 680.40K | 1.04M |
| Cash from Operations | -4.92M | -3.52M | -2.91M | -1.82M | -265.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 38.30K | 38.30K | 38.30K |
| Total Debt Issued | 10.30M | 9.81M | 3.05M | 3.05M | 0.00 |
| Total Debt Repaid | -3.73M | -3.72M | -221.40K | -221.40K | -- |
| Issuance of Common Stock | 811.30K | 265.80K | 265.80K | 28.60K | 257.70K |
| Repurchase of Common Stock | 0.00 | 0.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.45M | -907.50K | 0.00 | 265.80K | -- |
| Cash from Financing | 5.92M | 5.45M | 3.09M | 3.12M | 257.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.00M | 1.93M | 186.60K | 1.30M | -7.60K |